Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein
Baldari, C.T.; Pelicci, G.; Di Somma, M.M.; Milia, E.; Giuli, S.; Pelicci, P.G.; Telford, J.L.
Oncogene 10(6): 1141-1147
1995
ISSN/ISBN: 0950-9232 PMID: 7700640 Document Number: 449172
T-cell antigen receptor stimulation results in phosphorylation of the SH2 containing Shc proteins and recruitment of the Grb2/mSos complex suggesting that Shc proteins are involved in transducing T-cell activating signals to Ras. We have measured the effects of the isolated Shc-SH2 domain and the dominant negative Ras-N17 protein on activation of the T-cell specific transcription factor NF-AT. The isolated Shc-SH2 domain was designed to compete with endogenous She binding to upstream tyrosine phosphorylated proteins and to interfere with coupling to regulators of Ras activation. We have demonstrated thta both the Shc-SH2 domain and the Ras-N17 protein significantly inhibited NF-AT activation by the CD4 coreceptor and the CD4 associated tyrosine kinase p56-lck. In contrast, only the Ras-N17 prein reduced NF-AT activtion by the TCR/CD3 complex. Furthermore, tyrosine kinase activity and p56-lck protein were found in complexes immunoprecipitated with Shc specific antisera after CD4 triggering but not after CD3 triggering. These results indicate that both CD4 and CD3 signal to Ras and that this signaling is mediated by independent pathways of activation of the Shc adaptor protein.